Search Results - "Joseph, D.J"

9 TARGIT by Joseph, D.J

Get full text

Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized Trial by MacManus, M.P, Fisher, R, Roos, D, O'Brien, P, Macann, A.M.J, Christie, D, Tsang, R.W, Davis, S.R, Joseph, D.J, McClure, B, Seymour, J

Get full text

PO-0873: Modelling severe late rectal bleeding in a large pooled population of prostate cancer patients by Cicchetti, A, Rancati, T, Ebert, M, Fiorino, C, Kennedy, A, Joseph, D.J, Denham, J.W, Vavassori, V, Fellin, G, Valdagni, R

Get full text

PD-0547: GI dose constraints for prostate radiotherapy: Derivation by toxicity and localised anatomy by Ebert, M.A, Gulliford, S, Foo, K, Haworth, A, Kennedy, A, Joseph, D.J, Denham, J.W

Get full text

Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population by Cicchetti, A, Rancati, T, Ebert, M, Fiorino, C, Palorini, F, Kennedy, A, Joseph, D.J, Denham, J.W, Vavassori, V, Fellin, G, Avuzzi, B, Stucchi, C, Valdagni, R

“…Highlights • NTCP models were developed for stool frequency/rectal pain after 3DCRT. • A pooled population was investigated. • More than 1000 patients…”
Get full text

OC-0472: Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT Atrial by Vaidya, J, Bulsara, M, Wenz, F, Tobias, J.S, Joseph, D.J, Massarut, S, Flyger, H, Eiermann, W, Saunders, C, Alvarado, M, Brew-Graves, C, Potyka, I, Williams, N.R, Baum, M

Get full text

PO-323 COSMETIC OUTCOME AFTER INTRA-OPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER IN WOMEN OVER 50 YEARS by Williams, N, Keshtgar, M, Corica, T, Saunders, C, Bulsara, M, Joseph, D.J

Get full text

OC-0080: Treatment factors impacting on gastrointestinal toxicity following prostate radiotherapy by Ebert, M, Bulsara, M, Haworth, A, Kearvell, R, Kennedy, A, Richardson, S, Krawiec, M, Stewart, N, Joseph, D.J, Denham, J.W

Get full text

Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications by Gulliford, S.L., Ghose, S., Ebert, M.A., Kennedy, A., Dowling, J., Mitra, J., Joseph, D.J., Denham, J.W.

“…Traditionally rectal symptoms following pelvic/prostate radiotherapy are correlated to the dosimetry of the anorectum or a substructure of this. It has been…”
Get full text

Modelling severe late rectal bleeding: Results on a large pooled population of prostate cancer patients by Cicchetti, A, Rancati, T, Ebert, M, Fiorino, C, Kennedy, A, Joseph, D.J, Denham, J.W, Vavassori, V, Fellin, G, Valdagni, R

Get full text

7104 ORAL Bone Mineral Density Loss and Fractures in the TROG 03.04 (RADAR) Trial by Denham, J.W, Ball, J.I, Joseph, D.J, Lamb, D.S, Duchesne, G.M, Diamond, T, Nowitz, M, Rowan, D, Lynch, K, Woodfield, R

Get full text

7101 ORAL Variations in Androgen Dependent Clinical Progression Kinetics in Locally Advanced Prostate Cancer by Denham, J, Steigler, A, Lamb, D.S, Joseph, D.J, Matthews, J, Atkinson, C, Spry, N.A, D'Este, C

Get full text

P265 Cosmetic outcome one, two, three and four years after intra-operative radiotherapy compared with external beam radiotherapy for early breast cancer: an objective assessment of patients from a randomised controlled trial by Keshtgar, M, Williams, N.R, Corica, T, Saunders, C, Joseph, D.J, Bulsara, M.K

Get full text

Financial Difficulties and Long-Term Oncological Outcomes Following Prostate Radiotherapy and Androgen Deprivation Therapy – Post-Hoc Analyses of TROG0304/ RADAR Trial by Ong, W.L., Joseph, D.J., Millar, J.L., Kishan, A.U.

“…Several studies have reported the impact of financial toxicities of cancer treatment. However, its impact in countries with public health systems, such as…”
Get full text

Patient-Reported Urinary and Bowel Quality of Life Outcomes Following External Beam Radiotherapy with or without High-Dose-Rate Brachytherapy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR) by Ong, W.L., Nikitas, J., Joseph, D.J., Steigler, A., Denham, J.W., Millar, J.L., Valle, L., Steinberg, M.L., Ma, T.M., Chang, A.J., Zaorsky, N.G., Spratt, D.E., Romero, T., Kishan, A.U.

“…One of the concerns with combining external beam radiotherapy (EBRT) with a high dose rate brachytherapy boost (HDRBT) for prostate cancer is increased…”
Get full text

Natural History after Likely Cure vs. Recurrence vs. after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials by Roy, S., Romero, T., Roach, M., Michalski, J.M., Joseph, D.J., Dearnaley, D., Tree, A., Incrocci, L., Heemsbergen, W., Bolla, M., Nabid, A., Armstrong, J.G., Malone, S., Horwitz, E.M., Wong, J.K., Arcangeli, S., Sanguineti, G., Zapatero, A., Spratt, D.E., Kishan, A.U.

“…Conventionally, patients who do not experience a biochemical recurrence (BCR) within 5 years of radiotherapy (RT) for non-metastatic prostate cancer (PCa) are…”
Get full text

OC-0211: Bladder and Urethra Subregions for Prediction of Urinary Toxicity: Insights from External Validation by Mylona, E., Ebert, M., Kennedy, A., Denham, J.W., Joseph, D.J., Steigler, A., Acosta, O., De Crevoisier, R.

Get full text

Development and External Validation of a Predictive Model of Urethra Toxicity for Patients Treated with HDR Brachytherapy Boost Including the Effect of Neo-Adjuvant Androgen Deprivation by Panettieri, V., Rancati, T., Onjukka, E., Smith, R.L., Ebert, M.A., Joseph, D.J., Denham, J.W., Steigler, A., Millar, J.L.

Get full text

PV-0321: Influence of urethra contouring on NTCP models predicting urethral strictures in prostate HDRB by Panettieri, V., Rancati, T., Onjukka, E., Smith, R.L., Ebert, M.A., Joseph, D.J., Denham, J.W., Steigler, A., Millar, J.L.

Get full text

Impact of High DosE rAdioTherapy (HEAT) in Localized Prostate Cancer: An Individual Patient Data (IPD) Meta-Analysis of 15 Randomized Trials by Kishan, A.U., Romero, T., Wang, X., Pisansky, T.M., Roach, M., Bolla, M., Steigler, A., Denham, J.W., Shipley, W.U., Sandler, H.M., Feng, F.Y., Joseph, D.J., Armstrong, J.G., Dunne, M., Malone, S., Roy, S., Zapatero, A., Sun, Y., Michalski, J.M., Spratt, D.E.

“…Radiotherapy (RT) dose escalation for localized prostate cancer has not demonstrated improvement in overall survival (OS) from individual trials. It is unclear…”
Get full text